Turmeric for Patients With Basal Joint Arthritis
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Turmeric, Placebo.
- Who it may be relevant to
- Registry conditions: Thumb Osteoarthritis. Basic parameters: from 40 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
A Randomized Controlled Trial Using Turmeric for Patients With Basal Joint Arthritis
Overview
The aim of this study is to assess whether the use of a commercially available nutraceutical, turmeric, is an effective option to manage pain and stiffness in patients with basal joint arthritis. To conduct a pilot Randomized Controlled Trial evaluating the impact of turmeric on basal joint arthritis.
Interventions
- Dietary supplement Turmeric
Subjects will receive turmeric (100 mg pastille) 3 times per day for 6 weeks. - Other Placebo
Subjects in the control group will receive a placebo 3 times per day for 6 weeks.
Primary outcome measures
- Change in baseline pain intensity [Time frame: Enrollment, 6 weeks, and 3 months]
- Change in baseline disability [Time frame: Enrollment, 6 weeks, and 3 months]
Eligibility criteria
Inclusion criteria
- 40 years of age or older
- English fluency and literacy
- Seeking care for basal joint pain
- Tender over basal joint
- Positive distraction rotation test (rotation of the thumb metacarpal base while applying axial traction)
- Radiographic evidence of Eaton stage 1 and 2 only
Exclusion criteria
- Secondary gains (litigations or worker compensation) procedures that may interfere with patients' motivation for treatment
- Inability or unwillingness to participate in a trial study
- Rheumatoid Arthritis or other inflammatory disorder diagnoses
- Post-traumatic osteoarthritis
- Patients on Coumadin/Steroids/NSAIDs/Tylenol
- Diabetes Mellitus
- Pregnant or lactating women
- Basal joint arthritis of Eaton stage 3
- Patients seeking other treatment for their basal joint arthritis (splint, corticosteroid injection, surgery)
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Quadruple blind
- Primary purpose
- Treatment
Study locations
United States · 1 center
- Massachusetts General Hospital — Boston
Identifiers
NCT: NCT03017118 · 2016P001402